Identification of a receptor for BLyS demonstrates a crucial role in humoral immunity

Nature Immunology

Volumn 1, Issue 1, 2000, Pages 37-41

  Yan, Minhong ^a   Marsters, Scot A ^a   Grewal, Iqbal S ^a   Wang, Hua ^a   Ashkenazi, Avi ^a   Dixit, Vishva M ^a  

^a GENENTECH INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B CELL ACTIVATING FACTOR; IMMUNOGLOBULIN RECEPTOR; MEMBRANE PROTEIN; TNFSF13B PROTEIN, HUMAN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR;

ANIMAL; ANTIBODY PRODUCTION; ARTICLE; CELL STRAIN COS1; GENETICS; HUMAN; IMMUNOLOGY; MOLECULAR CLONING; SIGNAL TRANSDUCTION;

ANIMALS; ANTIBODY FORMATION; B-CELL ACTIVATING FACTOR; CLONING, MOLECULAR; COS CELLS; HUMANS; MEMBRANE PROTEINS; RECEPTORS, IMMUNOLOGIC; RECEPTORS, TUMOR NECROSIS FACTOR; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0034232338     PISSN: 15292908     EISSN: None     Source Type: Journal    
DOI: 10.1038/76889     Document Type: Article

References (42)

1. Gruss, H.J. & Dower, S. K. Tumor necrosis factor ligand superfamily: involvement in the pathology of malignant lymphomas. Blood 85, 3378-3404 (1995).
2. Smith, C.A., Farrah, T. & Goodwin, R. G. The TNF receptor superfamily of cellular and viral proteins: activation, costimulation, and death. Cell 76, 959-962 (1994).
3. Ashkenazi, A. & Dixit, V. M. Death receptors: signling and modulation. Science 281, 1305-1308 (1998).
4. Moore, P.A. et al. BLyS: member of the tumor necrosis factor family and B lymphocyte stimulator. Science 285, 260-263 (1999).
5. Shu, H. B., Hu, W. H. & Johnson, H. TALL-1 is a novel member of the TNF family that is down-regulated by mitogens. J. Leukocyte Biol. 65, 680-683 (1999).
6. Mukhopadhyay, A., Ni, J., Zhai, Y., Yu, G. L. & Aggarwal, B. B. Identification and characterization of a novel cytokine, THANK, a TNF homologue that activates apoptosis, nuclear factor-kappaB, and c-Jun NH2-terminal kinase. J. Biol. Chem. 274, 15978-15981 (1999).
7. Schneider, P. et al. BAFF, a novel ligand of the tumor necrosis factor family, stimulates B cell growth. J. Exp. Med. 189, 1747-1756 (1999).
8. Mackay, F. et al. Mice transgenic for BAFF develop lymphocytic disorders along with autoimmune manifestations. J. Exp. Med 190, 1697-1710 (1999).
9. Kahre, S. D. et al. Severe B cell hyperplasia and autoimmune disease in TALL-I transgenic mice. Proc. Natl Acad Sci USA 97, 3370-3375 (2000).
10. Flanagan, J. G. & Leder, P. The kit ligand: a cell surface molecule altered in steel mutant fibroblasts. Cell 63, 185-194 (1990).
11. von Bulow, G. U. & Bram, R. J. NF-AT activation induced by a CAML-interacting member of the tumor necrosis factor receptor superfamily. Science 278, 138-141 (1997).
12. Pennica, D. et al. Human tumour necrosis factor: precursor structure, expression and homology to lymphotoxin. Nature 312, 724-729 (1984).
13. Mauri, D. et al. LIGHT, a new member of the TNF superfamily, and lymphotoxin alpha are ligands for Herpesvirus Entry Mediator. Immunity 8, 21-30 (1998).
14. Ashkenazi, A. et al. Protection against endotoxic shock by a tumor necrosis factor receptor immunoadhesin. Proc. Natl Acad. Sci. USA 88,1053S-10539 (1991).
15. Pitti, R. M. et al. Induction of apoptosis by Apo-2 Ligand, a new member of the tumor necrosis factor receptor family. J. Biol. Chem. 271, 12697-12690 (1996).
16. Marsters, S.A. et al. Identification of a ligand for the death-domain-containing receptor Apo3. Curr. Biol. 8, 525-528 (1998).
17. Wong, B. R. et al. TRANCE is a novel ligand of the TNFR family that activates c-Jun-N-terminal kinase in T cells. J. Biol. Chem. 272, 25190-25194 (1997).
18. Tan, K. et al. Characterization of a novel TNF-like ligand and recently described TNF ligand and TNF receptor superfamily genes and their constitutive and inducible expression in hematopoietic and non-hematopoietic cells. Gene 204, 35-46 (1997).
19. Gurney, A. et al. Identification of a new member of the tumor necrosis factor family and its receptor, a human ortholog of mouse GITR. Curr. Biol. 9, 215-221 (1999).
20. Marsters, S. et al. HVEM, a member of the TNF receptor family, interacts with members of the TRAF family and activates the transcription factors NF-kB and AP-1. J. Biol. Chem. 272, 14029-14032 (1997).
21. Chinnaiyan, A. M. et al. Signal transduction by DR3, a death domain-containing receptor related to TNFR-I and CD95. Science 274, 990-992 (1996).
22. Marsters, S. et al. Apo3, a new member of the tumor necrosis factor receptor family, contains a death domain and activates apoptosis and NF-κB. Curr. Biol. 6, 1669-1676 (1996).
23. Pan, G. et al. Identification and functional characterization of DR6, a novel death domain-containing TNF receptor. FEBS Lett 431, 351-356 (1998).
24. Gray, D. Recruitment of virgin B cells into an immune response is restricted to activation outside lymphoid follicles. Immunology 65, 73-79 (1988).
25. MacLennan, I. C. Germinal centers. Annu. Rev. Immunol. 12, 117-139 (1994).
26. Matsumoto, M. et al. Affinity maturation without germinal centres in lymphotoxin-alpha-deficient mice. Nature 382, 462-466 (1996).
27. Kato, J. et al. Affinity maturation in Lyn kinase-deficient mice with defective germinal center formation. J. Immunol. 160, 4788-4795 (1998).
28. Futterer, A., Mink, K., Luz, A., Kosco-Vilbois, M. H. & Pfeffer, K. The lymphotoxin beta receptor controls organogenesis and affinity maturation in peripheral lymphoid tissues. Immunity 9, 59-70 (1998).
29. Foy, T. M., Aruffo, A., Bajorath, J., Buhlmann, J. E. & Noelle, R.J. Immune regulation by CD40 and its ligand GP39. Annu. Rev. Immunol. 14, 591-617 (1996).
30. Han, S. et al. Cellular interaction in germinal centers. Roles of CD40 ligand and B7-2 in established germinal centers. J. Immunol. 155, 556-567 (1995).
31. Lenschow, D.J., Walunas, T.L. & Bluestone, J. A. CD28/B7 system of T cell costimulation. Annu. Rev. Immunol. 14, 233-258 (1996).
32. Lane, P. et al. B cell function in mice transgenic for mCTLA4-H gamma I: lack of germinal centers correlated with poor affinity maturation and class switching despite normal priming of CD4+T cells. J. Exp. Med. 179, 819-830 (1994).
33. Durie, F. H., Foy, T. M., Masters, S. R., Laman, J. D. & Noelle, R. J. The role of CD40 in the regulation of humoral and cell-mediated immunity. Immunol. Today 15, 406-411 (1994).
34. Hathcock, K. S. et al. Identification of an alternative CTLA-4 ligand costimulatory for T cell activation [see comments]. Science 262, 905-907 (1993).
35. Linsley, P. S. et al. Immunosuppression in vivo by a soluble form of the CTLA-4 T cell activation molecule. Science 257, 792-795 (1992).
36. Renshaw, B. R. et al. Humoral immune responses in CD40 ligand-deficient mice. J. Exp. Med. 180, 1889-1900 (1994).
37. Xu, J. et al. Mice deficient for the CD40 ligand. Immunity 1, 423-431 (1994).
38. Kawabe, T. et al. The immune responses in CD40-deficient mice: impaired immunoglobulin class switching and germinal center formation. Immunity 1, 167-178 (1994).
39. Foy, T. M. et al. gp39-CD40 interactions are essential for germinal center formation and the development of B cell memory. J. Exp. Med. 180, 157-163 (1994).
40. Callard, R. E., Armitage, R. J., Fanslow, W. C. & Spriggs, M. K. CD40 ligand and its role in X-linked hyper-IgM syndrome. Immunol. Today 14, 559-564 (1993).
41. Allen, R. C. et al. CD40 ligand gene defects responsible for X-linked hyper-IgM syndrome. Science 259, 990-993 (1993).
42. Aruffo, A. et al. The CD40 ligand, gp39, is defective in activated T cells from patients with X-linked hyper-IgM syndrome. Cell 72, 291-300 (1993).